These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 22945591)

  • 61. Gout and Metabolic Syndrome: a Tangled Web.
    Thottam GE; Krasnokutsky S; Pillinger MH
    Curr Rheumatol Rep; 2017 Aug; 19(10):60. PubMed ID: 28844079
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MSU crystal deposition contributes to inflammation and immune responses in gout remission.
    Gu H; Yu H; Qin L; Yu H; Song Y; Chen G; Zhao D; Wang S; Xue W; Wang L; Ai Z; Xu B; Peng A
    Cell Rep; 2023 Oct; 42(10):113139. PubMed ID: 37756161
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mechanisms of crystal formation in gout-a structural approach.
    Pascual E; Addadi L; Andrés M; Sivera F
    Nat Rev Rheumatol; 2015 Dec; 11(12):725-30. PubMed ID: 26369610
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lymphocyte α-kinase is a gout-susceptible gene involved in monosodium urate monohydrate-induced inflammatory responses.
    Wang SJ; Tu HP; Ko AM; Chiang SL; Chiou SJ; Lee SS; Tsai YS; Lee CP; Ko YC
    J Mol Med (Berl); 2011 Dec; 89(12):1241-51. PubMed ID: 21822924
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Why does the gout attack stop? A roadmap for the immune pathogenesis of gout.
    Schett G; Schauer C; Hoffmann M; Herrmann M
    RMD Open; 2015; 1(Suppl 1):e000046. PubMed ID: 26557370
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Recent advances in the pathophysiology of hyperuricemia and gout].
    So A
    Rev Med Suisse; 2007 Mar; 3(103):720, 722-4. PubMed ID: 17458149
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Pyroptotic Cell Death Effector Gasdermin D Is Activated by Gout-Associated Uric Acid Crystals but Is Dispensable for Cell Death and IL-1β Release.
    Rashidi M; Simpson DS; Hempel A; Frank D; Petrie E; Vince A; Feltham R; Murphy J; Chatfield SM; Salvesen GS; Murphy JM; Wicks IP; Vince JE
    J Immunol; 2019 Aug; 203(3):736-748. PubMed ID: 31209100
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Crystal-induced neutrophil activation.
    Popa-Nita O; Naccache PH
    Immunol Cell Biol; 2010 Jan; 88(1):32-40. PubMed ID: 19949421
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Combined effects of MSU crystals injection and high fat-diet feeding on the establishment of a gout model in C57BL/6 mice.
    Lin X; Shao T; Wen X; Wang M; Wen C; He Z
    Adv Rheumatol; 2020 Nov; 60(1):52. PubMed ID: 33148336
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
    Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
    J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The inflammatory role of silent urate crystal deposition in intercritical gout.
    Diaz-Torne C; Ortiz MA; Garcia-Guillen A; Jeria-Navarro S; Sainz L; Fernandez-Sanchez S; Corominas H; Vidal S
    Rheumatology (Oxford); 2021 Nov; 60(11):5463-5472. PubMed ID: 33839783
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals.
    Scanu A; Oliviero F; Gruaz L; Sfriso P; Pozzuoli A; Frezzato F; Agostini C; Burger D; Punzi L
    Arthritis Res Ther; 2010; 12(1):R23. PubMed ID: 20149224
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role of miR-146a in regulation of the acute inflammatory response to monosodium urate crystals.
    Dalbeth N; Pool B; Shaw OM; Harper JL; Tan P; Franklin C; House ME; Cornish J; Naot D
    Ann Rheum Dis; 2015 Apr; 74(4):786-90. PubMed ID: 25646371
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New insights into the epidemiology of gout.
    Doherty M
    Rheumatology (Oxford); 2009 May; 48 Suppl 2():ii2-ii8. PubMed ID: 19447779
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Beneficial Properties of Phytochemicals on NLRP3 Inflammasome-Mediated Gout and Complication.
    Jhang JJ; Lin JH; Yen GC
    J Agric Food Chem; 2018 Jan; 66(4):765-772. PubMed ID: 29293001
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages.
    Renaudin F; Orliaguet L; Castelli F; Fenaille F; Prignon A; Alzaid F; Combes C; Delvaux A; Adimy Y; Cohen-Solal M; Richette P; Bardin T; Riveline JP; Venteclef N; Lioté F; Campillo-Gimenez L; Ea HK
    Ann Rheum Dis; 2020 Nov; 79(11):1506-1514. PubMed ID: 32699039
    [TBL] [Abstract][Full Text] [Related]  

  • 77. P2Y6 Receptor Antagonist MRS2578 Inhibits Neutrophil Activation and Aggregated Neutrophil Extracellular Trap Formation Induced by Gout-Associated Monosodium Urate Crystals.
    Sil P; Hayes CP; Reaves BJ; Breen P; Quinn S; Sokolove J; Rada B
    J Immunol; 2017 Jan; 198(1):428-442. PubMed ID: 27903742
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Advances in our understanding of gout as an auto-inflammatory disease.
    Bodofsky S; Merriman TR; Thomas TJ; Schlesinger N
    Semin Arthritis Rheum; 2020 Oct; 50(5):1089-1100. PubMed ID: 32916560
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Crystal deposition in the knee and great toe joints of asymptomatic gout patients.
    Kennedy TD; Higgens CS; Woodrow DF; Scott JT
    J R Soc Med; 1984 Sep; 77(9):747-50. PubMed ID: 6481756
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Role of Inhibitory Receptors in Monosodium Urate Crystal-Induced Inflammation.
    Fernandes MJ; Naccache PH
    Front Immunol; 2018; 9():1883. PubMed ID: 30177932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.